These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells. Wang Y; Matsuo H; Kurachi O; Maruo T Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853 [TBL] [Abstract][Full Text] [Related]
5. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers. Furui T; Imai A; Tamaya T Oncol Rep; 2002; 9(2):349-52. PubMed ID: 11836606 [TBL] [Abstract][Full Text] [Related]
6. GnRH receptor and apoptotic signaling. Imai A; Tamaya T Vitam Horm; 2000; 59():1-33. PubMed ID: 10714235 [TBL] [Abstract][Full Text] [Related]
7. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines. Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040 [TBL] [Abstract][Full Text] [Related]
8. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. Gründker C; Günthert AR; Millar RP; Emons G J Clin Endocrinol Metab; 2002 Mar; 87(3):1427-30. PubMed ID: 11889221 [TBL] [Abstract][Full Text] [Related]
9. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591 [TBL] [Abstract][Full Text] [Related]
10. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN]. Zhao LJ; Wei LH; Li XP; Wang JL Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062 [TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238 [TBL] [Abstract][Full Text] [Related]
12. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma. Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150 [TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2. Wu HM; Wang HS; Huang HY; Lai CH; Lee CL; Soong YK; Leung PC BMC Cancer; 2013 Jun; 13():300. PubMed ID: 23786715 [TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha. Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794 [TBL] [Abstract][Full Text] [Related]
15. Lack of evidence for expression of Fas ligand in Fas-bearing tumors. Takagi A; Imai A; Horibe S; Ohno T; Tamaya T Oncol Rep; 1998; 5(2):377-80. PubMed ID: 9468561 [TBL] [Abstract][Full Text] [Related]
16. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells. Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298 [TBL] [Abstract][Full Text] [Related]
17. Direct effects of GnRH agonists in human hormone-sensitive endometrial cells. Sica G; Schinzari G; Angelucci C; Lama G; Iacopino F Mol Cell Endocrinol; 2001 May; 176(1-2):121-8. PubMed ID: 11369451 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Britten JL; Malik M; Levy G; Mendoza M; Catherino WH Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846 [TBL] [Abstract][Full Text] [Related]
19. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. Imai A; Takagi H; Horibe S; Fuseya T; Tamaya T J Clin Endocrinol Metab; 1996 Sep; 81(9):3249-53. PubMed ID: 8784077 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase. Gründker C; Völker P; Emons G Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]